Mechanisms Behind the Inhibition of Lung Adenocarcinoma Cell by Shikonin

An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas

(2013) Yu Wang et al.   Diagnostic Pathology

MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1

(2013) Yaqing Chen et al.   JOURNAL OF BIOSCIENCES

Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells

(2013) Kai-Lee Wang et al.   PLoS One

EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity

(2012) Elena Galvani et al.   Future Oncology

Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma

(2011) Ke Gong et al.   FREE RADICAL BIOLOGY AND MEDICINE

Effects of polybrominated diphenyl ethers on steroidogenesis in rat Leydig cells

(2011) Kai-Lee Wang et al.   HUMAN REPRODUCTION

Shikonin Induces Apoptosis through Reactive Oxygen Species/Extracellular Signal-Regulated Kinase Pathway in Osteosarcoma Cells

(2010) I-Chang Chang et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma

(2010) Chen-Chen Lee et al.   BRITISH JOURNAL OF PHARMACOLOGY

“Where, O Death, Is Thy Sting?” A Brief Review of Apoptosis Biology

(2010) Andrew H. Wyllie   MOLECULAR NEUROBIOLOGY

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

(2009) Fei Ma et al.   LUNG CANCER

Naturally-occurring shikonin analogues – A class of necroptotic inducers that circumvent cancer drug resistance

(2008) Yanyan Xuan et al.   CANCER LETTERS

Shikonin exerts antitumor activityviaproteasome inhibition and cell death inductionin vitroandin vivo

(2008) Huanjie Yang et al.   INTERNATIONAL JOURNAL OF CANCER